bisbenzimidazole has been researched along with magnolol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiao, G; Li, M; You, Q | 1 |
| Bi, Y; Jiang, Y; Khan, M; Ma, T; Meng, F; Yang, C; Yang, H; Yang, J; Yu, B; Zhou, Y | 1 |
2 other study(ies) available for bisbenzimidazole and magnolol
| Article | Year |
|---|---|
Magnolol induces apoptosis via activation of both mitochondrial and death receptor pathways in A375-S2 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Biphenyl Compounds; Bisbenzimidazole; Blotting, Western; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Nucleus; Cell Survival; Coloring Agents; DNA Fragmentation; DNA, Neoplasm; fas Receptor; Humans; Lignans; Melanoma, Experimental; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Receptors, Death Domain; Signal Transduction | 2009 |
Magnolol induces apoptosis in MCF-7 human breast cancer cells through G2/M phase arrest and caspase-independent pathway.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Inducing Factor; Biphenyl Compounds; Bisbenzimidazole; Breast Neoplasms; Caspases; Cell Division; Cell Line, Tumor; Cell Proliferation; Coloring Agents; Cytochromes c; Female; Flow Cytometry; G2 Phase; Genes, bcl-2; Humans; Indicators and Reagents; Lignans; Membrane Potential, Mitochondrial; Mitochondria; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles | 2013 |